Results 1 to 10 of about 1,414 (186)

Differential efficacy of Conbercept vs. Ranibizumab on retinal microstructural changes in macular edema secondary to retinal vein occlusion during the loading phase [PDF]

open access: yesFrontiers in Medicine
ObjectiveTo compare the efficacy of Conbercept vs.Ranibizumab on retinal microstructural changes in patients with retinal vein occlusion-associated macular edema (RVO-ME) by evaluating multidimensional OCT biomarkers during the loading phase.MethodsThis ...
Haiyue Yu   +6 more
doaj   +3 more sources

Conbercept combined with 577 nm subthreshold micropulse laser for diabetic macular edema [PDF]

open access: yesInternational Journal of Ophthalmology
AIM: To evaluate the efficacy and safety of conbercept combined with 577 nm subthreshold micropulse laser (STML) for treatment of diabetic macular edema (DME). METHODS: A retrospective study was conducted.
Ying Han   +7 more
doaj   +4 more sources

Recent advances in the study of Conbercept for diabetic macular edema [PDF]

open access: yesInternational Journal of Retina and Vitreous
Diabetic macular edema (DME) is one of the leading causes of blindness in diabetic retinopathy. As a domestically developed fusion protein drug in China, the anti-vascular endothelial growth factor (VEGF) agent Conbercept has demonstrated significant ...
Zhe Liu, Xin Zheng, Hong Li
doaj   +4 more sources

Intravitreal conbercept injection for neovascular age-related macular degeneration [PDF]

open access: yesInternational Journal of Ophthalmology, 2019
AIM: To evaluate the efficacy and safety of intravitreal injection of conbercept in patients with neovascular age-related macular degeneration (AMD). METHODS: Retrospective review of 66 eyes of 63 patients with neovascular AMD. All patients received 0.5
Bing-Hui Wu   +4 more
exaly   +4 more sources

Efficacy and safety of ranibizumab, aflibercept, and conbercept in the treatment of diabetic macular edema: a retrospective comparative study [PDF]

open access: yesScientific Reports
To compare the efficacy and safety of three first-line anti-vascular endothelial growth factor (anti-VEGF) agents: ranibizumab, aflibercept, and conbercept in the treatment of diabetic macular edema (DME).
Bowei Liu, Qian Qiao, Yalong Dang
doaj   +2 more sources

Comparison of conbercept and ranibizumab for the treatment of idiopathic choroidal neovascularization using optical coherence tomography angiography and multifocal electroretinography [PDF]

open access: yesFrontiers in Pharmacology
ObjectiveThis study aimed to compare the efficacies of conbercept and ranibizumab for the treatment of idiopathic choroidal neovascularization (ICNV) using optical coherence tomography angiography (OCTA) and multifocal electroretinography (mfERG ...
Gaixia Zhai   +3 more
doaj   +2 more sources

Anti-Vascular Endothelial Growth Factor Combined with Dexamethasone Implant Therapy for Macular Edema: A Randomized Controlled Trial [PDF]

open access: yesDrug Design, Development and Therapy
Yunxi Ma, Junwen Wang, Mingzhu Yuan, Zimeng Zeng, Yuhe Tan, Lu Cao, Xufang Sun Department of Ophthalmology, Hubei Key Laboratory of Otolaryngologic and Ophthalmic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and ...
Ma Y   +6 more
doaj   +2 more sources

Enhancement of retinal Müller glia’s phagocytic activity against hard exudates by conbercept via activation of PPARγ-CD36 axis in diabetic retinopathy [PDF]

open access: yesInternational Journal of Ophthalmology
AIM: To investigate the effects and the underlying mechanism(s) of conbercept on the phagocytosis of hard exudates (HEs) by Müller glia in diabetic retinopathy (DR).
Ying-Ying Zhu   +7 more
doaj   +2 more sources

Efficacy of Intravitreal Conbercept in Vitrectomy for Proliferative Diabetic Retinopathy: An Integrated Meta-Analysis and Bibliometric Study [PDF]

open access: yesClinical Ophthalmology
Guangda Li,1,* Mingxuan Zhang,2,* Yifeng Ke,2 Chuanzhen Zheng,3 Liangzhang Tan,2 Yongtao Li,2 Emmanuel Eric Pazo,2 Chunli Chen,4 Xinjun Ren2 1Department of Ophthalmology, Linyi People’ s Hospital, Linyi, Shandong, People’s Republic of ...
Li G   +8 more
doaj   +2 more sources

Ocular pharmacokinetics of intravitreal conbercept in a rabbit model following retinal scatter laser photocoagulation [PDF]

open access: yesFrontiers in Pharmacology
ObjectiveThe present study aims to evaluate the ocular pharmacokinetics of intravitreal conbercept after retinal scatter laser photocoagulation.MethodsThirty male Chinchilla rabbits (60 eyes) were used in this study.
Lanlan Chen   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy